Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
12.72
+0.06 (0.47%)
At close: Sep 5, 2025, 4:00 PM
12.77
+0.05 (0.39%)
After-hours: Sep 5, 2025, 6:01 PM EDT
Avanos Medical Revenue
Avanos Medical had revenue of $175.00M in the quarter ending June 30, 2025, with 1.92% growth. This brings the company's revenue in the last twelve months to $692.50M, up 1.48% year-over-year. In the year 2024, Avanos Medical had annual revenue of $687.80M with 2.15% growth.
Revenue (ttm)
$692.50M
Revenue Growth
+1.48%
P/S Ratio
0.85
Revenue / Employee
$310,956
Employees
2,227
Market Cap
590.24M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 687.80M | 14.50M | 2.15% |
Dec 31, 2023 | 673.30M | -10.80M | -1.58% |
Dec 31, 2022 | 684.10M | 97.10M | 16.54% |
Dec 31, 2021 | 587.00M | -127.80M | -17.88% |
Dec 31, 2020 | 714.80M | 17.20M | 2.47% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
AVNS News
- 7 days ago - The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice - Seeking Alpha
- 4 weeks ago - Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors - PRNewsWire
- 4 weeks ago - Avanos Medical, Inc. Announces Second Quarter 2025 Results - PRNewsWire
- 5 weeks ago - Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical - PRNewsWire
- 6 weeks ago - Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results - PRNewsWire
- 3 months ago - Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer - PRNewsWire
- 4 months ago - Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript - Seeking Alpha